K. Liphardt

Selective Modulation of the Protease Activated Protein C Using Exosite Inhibiting Aptamers.

J. Oldenburg, G. Mayer, Fabian Tolle, 2020, Nucleic acid therapeutics.

Galpha(q)-mediated plasma membrane translocation of sphingosine kinase-1 and cross-activation of S1P receptors.

K. Jakobs, T. Hla, N. Ktistakis, 2009, Biochimica et biophysica acta.

Variants in FIX propeptide associated with vitamin K antagonist hypersensitivity: functional analysis and additional data confirming the common founder mutations

J. Oldenburg, A. Pavlova, S. Ulrich, 2018, Annals of Hematology.

Two enzymes catalyze vitamin K 2,3-epoxide reductase activity in mouse: VKORC1 is highly expressed in exocrine tissues while VKORC1L1 is highly expressed in brain.

J. Oldenburg, K. Czogalla, M. Watzka, 2015, Thrombosis research.

Warfarin and vitamin K compete for binding to Phe55 in human VKOR

V. Hornung, A. Biswas, J. Oldenburg, 2016, Nature Structural &Molecular Biology.

Risk stratification integrating genetic data for factor VIII inhibitor development in patients with severe hemophilia A

C. Königs, P. Dönnes, S. Lacroix-Desmazes, 2019, PloS one.

VKORC1 and VKORC1L1 have distinctly different oral anticoagulant dose-response characteristics and binding sites.

V. Hornung, A. Biswas, J. Oldenburg, 2018, Blood advances.